Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.


 

NCCN Guidelines Update for ER+ Breast Cancer: CDK4/6 and PIK3CA Inhibitors for Advanced BC & Tamoxifen and Aromatase Inhibitors for Early BC

9,350 views
September 13, 2019
1 Comment
Login to view comments. Click here to Login